All-Cause and Cause-Specific Mortality in Psoriatic Arthritis and Ankylosing Spondylitis: A Systematic Review and Meta-Analysis
- PMID: 34788902
- PMCID: PMC9110556
- DOI: 10.1002/acr.24820
All-Cause and Cause-Specific Mortality in Psoriatic Arthritis and Ankylosing Spondylitis: A Systematic Review and Meta-Analysis
Abstract
Objective: Psoriatic arthritis (PsA) and ankylosing spondylitis (AS) are chronic inflammatory diseases associated with a higher risk of cardiometabolic comorbidities compared to the general population. Individual studies examining mortality in these patients have produced conflicting results. The present study was undertaken to perform a systematic review and meta-analysis to analyze the all-cause and cause-specific mortality in PsA and AS from the available literature.
Methods: A comprehensive database search was performed for studies reporting all-cause or cause-specific mortality in patients with PsA and AS compared with the general population. Pooled relative risks (RRs) were calculated using a random-effects model.
Results: We included 19 studies (11 of PsA, 7 of AS, 1 of both). In PsA studies, there was no increased mortality compared to the general population (RR 1.12 [95% confidence interval (95% CI) 0.96-1.30]; n = 10 studies). We found a higher all-cause mortality in female (RR 1.19 [95% CI 1.04-1.36]) but not in male (RR 1.02 [95% CI 0.66-1.59]) PsA patients. Cardiovascular-, respiratory-, and infection-specific mortality risks were significantly higher for PsA patients (RR 1.21 [95% CI 1.06-1.38], RR 3.37 [95% CI 1.30-8.72], and RR 2.43 [95% CI 1.01-5.84], respectively), but not cancer-related mortality (RR 1.01 [95% CI 0.91-1.11]). In AS, we found a higher risk of death from all causes (RR 1.64 [95% CI 1.49-1.80]; n = 6 studies) and cardiovascular causes (RR 1.35 [95% CI 1.01-1.81]; n = 3 studies) compared to the general population. All-cause mortality was high in both male (RR 1.56 [95% CI 1.43-1.71]) and female (RR 1.85 [95% CI 1.56-2.18]) AS patients. The included AS studies did not report mortality data for non-cardiovascular causes.
Conclusion: This systematic review and meta-analysis showed a significantly increased risk of overall mortality in AS but not PsA. Cardiovascular-specific mortality was higher for both PsA and AS, which emphasizes the importance of early screening and management of cardiovascular risk factors.
© 2021 American College of Rheumatology.
Figures
Similar articles
-
Cardiovascular risk profiles in a hospital-based population of patients with psoriatic arthritis and ankylosing spondylitis: a cross-sectional study.Rheumatol Int. 2017 Jan;37(1):113-120. doi: 10.1007/s00296-016-3614-0. Epub 2016 Nov 26. Rheumatol Int. 2017. PMID: 27889826
-
Incident myocardial infarction associated with major types of arthritis in the general population: a systematic review and meta-analysis.Ann Rheum Dis. 2017 Aug;76(8):1396-1404. doi: 10.1136/annrheumdis-2016-210275. Epub 2017 Feb 20. Ann Rheum Dis. 2017. PMID: 28219882 Review.
-
Are ankylosing spondylitis, psoriatic arthritis and undifferentiated spondyloarthritis associated with an increased risk of cardiovascular events? A prospective nationwide population-based cohort study.Arthritis Res Ther. 2017 May 18;19(1):102. doi: 10.1186/s13075-017-1315-z. Arthritis Res Ther. 2017. PMID: 28521824 Free PMC article.
-
Prevalence of cardiovascular-related comorbidity in ankylosing spondylitis, psoriatic arthritis and psoriasis in primary care: a matched retrospective cohort study.Clin Rheumatol. 2016 Dec;35(12):3069-3073. doi: 10.1007/s10067-016-3362-2. Epub 2016 Aug 2. Clin Rheumatol. 2016. PMID: 27485152
-
Cardiovascular risk profile of patients with spondylarthropathies, particularly ankylosing spondylitis and psoriatic arthritis.Semin Arthritis Rheum. 2004 Dec;34(3):585-92. doi: 10.1016/j.semarthrit.2004.07.010. Semin Arthritis Rheum. 2004. PMID: 15609262 Review.
Cited by
-
Dysregulated Non-Coding RNA Expression in T Cells from Patients with Ankylosing Spondylitis Contributes to Its Immunopathogenesis.Biomedicines. 2024 Aug 16;12(8):1873. doi: 10.3390/biomedicines12081873. Biomedicines. 2024. PMID: 39200337 Free PMC article. Review.
-
Multimorbidity phenotypes in ankylosing spondylitis and their association with disease activity and functional impairment: Data from the prospective study of outcomes in ankylosing spondylitis cohort.Semin Arthritis Rheum. 2024 Feb;64:152282. doi: 10.1016/j.semarthrit.2023.152282. Epub 2023 Nov 7. Semin Arthritis Rheum. 2024. PMID: 37995469
-
Long-Term Safety of Guselkumab in Patients with Psoriatic Disease: An Integrated Analysis of Eleven Phase II/III Clinical Studies in Psoriasis and Psoriatic Arthritis.Drug Saf. 2024 Jan;47(1):39-57. doi: 10.1007/s40264-023-01361-w. Epub 2023 Oct 31. Drug Saf. 2024. PMID: 37906417 Free PMC article. Clinical Trial.
-
A population-based projection of psoriatic arthritis in Germany until 2050: analysis of national statutory health insurance data of 65 million German population.Rheumatol Int. 2023 Nov;43(11):2037-2047. doi: 10.1007/s00296-023-05422-2. Epub 2023 Aug 19. Rheumatol Int. 2023. PMID: 37597059 Free PMC article.
-
Cardiovascular risk in axial spondyloarthritis-a systematic review.Clin Rheumatol. 2023 Oct;42(10):2621-2633. doi: 10.1007/s10067-023-06655-z. Epub 2023 Jul 7. Clin Rheumatol. 2023. PMID: 37418034 Free PMC article. Review.
References
-
- Yurkovich M, Vostretsova K, Chen W, Avina-Zubieta JA. Overall and cause-specific mortality in patients with systemic lupus erythematosus: a meta-analysis of observational studies. Arthritis Care Res (Hoboken). 2014;66:608–616. - PubMed
-
- Dadoun S, Zeboulon-Ktorza N, Combescure C, et al. Mortality in rheumatoid arthritis over the last fifty years: systematic review and meta-analysis. Joint Bone Spine. 2013;80:29–33. - PubMed
-
- Chou CH, Lin MC, Peng CL, Wu YC, Sung FC, Kao CH, et al. A nationwide population-based retrospective cohort study: increased risk of acute coronary syndrome in patients with ankylosing spondylitis. Scand J Rheumatol. 2014;43:132–6. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
